No insider purchase over the last 90 days. The latest, by Li Song, was filed 01 Nov 2024.
Frontage Holdings Corporation is a listed company. Its insiders report their share dealings to HKEX. Nothing new has been filed by managers of Frontage Holdings Corporation in twelve months, the latest record being from 30 May 2025.
Looking back to 2020, when coverage begins, insiders filed 8 purchases and 7 sales.
Elsewhere in the same market, our signals recently picked up insider purchases at Sun Hung Kai Properties Ltd. and Xinyi Glass Holdings Ltd. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 28 declarations
Frontage Holdings Corporation is a company listed on the Hong Kong Stock Exchange, specializing in research and development services for the pharmaceutical industry. It provides integrated solutions for drug development and clinical trials.
Purchases our model currently ranks for the recommendations list.
All recommendations